A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

Clinical trial NCT07428486 · WITHDRAWN

Trial details

NCT number: NCT07428486
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Phase I FLAG Chemotherapy Lisaftoclax Pelcitoclax Relapsed/Refractory Lymphoblastic Leukemia Acute

Start date: 2026-04-27
Primary completion: 2026-04-27
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.